Haizhou Pharma manufactures APIs, pharmaceutical intermediates, fine chemicals, and iodinated contrast media products for global pharmaceutical and healthcare markets.

We serve pharmaceutical, healthcare, medical imaging, and specialty chemical industries with products used in formulation, diagnostics, and therapeutic applications.

Our core strengths include Guaiacol derivatives, Epichlorohydrin derivatives, and contrast media APIs, supported by decades of manufacturing and process expertise.

Yes. We offer flexible CDMO and custom manufacturing solutions for both GMP and non-GMP projects with dedicated technical and project management teams.

Haizhou Pharma holds GMP, FDA, EDQM, MFDS, ISO 14001, ISO 45001, COPP certifications, and received the 2024 EcoVadis Silver Medal.

We operate three specialized R&D centers focused on process optimization, analytical validation, new product development, and CDMO collaboration projects.

Our 35-acre manufacturing site includes multifunctional production workshops, 14 GMP-approved APIs, 21 DMF-submitted products, and advanced production facilities.

We follow strict GMP management systems, international quality standards, and comprehensive quality control procedures throughout production and supply processes.

Customers value our stable supply capability, regulatory compliance, technical expertise, transparent communication, and long-term cooperation experience.

Haizhou Pharma supplies products and services to customers across North America, Europe, Asia, and other international pharmaceutical markets.